Ausgabe 4/2009
Inhalt (8 Artikel)
Induction of muscle weakness by local inflammation: an experimental animal model
S. Bicer, P. J. Reiser, S. Ching, N. Quan
Concentrations of α- and β-defensins in plasma of patients with inflammatory bowel disease
N. Yamaguchi, H. Isomoto, H. Mukae, H. Ishimoto, K. Ohnita, S. Shikuwa, Y. Mizuta, M. Nakazato, S. Kohno
Neutrophil elastase inhibitor (sivelestat) reduces the Levels of inflammatory mediators by inhibiting NF-kB
S. Hagiwara, H. Iwasaka, S. Hidaka, A. Hasegawa, T. Noguchi
A new model of outbred genetically selected mice which present a strong acute inflammatory response in the absence of complement component C5
M. T. Amano, A. S. Carneiro, O. G. Ribeiro, W. K. Cabrera, M. De Franco, O. M. Ibañez, L. Isaac, N. Starobinas
Suramin inhibits macrophage activation by human group IIA phospholipase A2, but does not affect bactericidal activity of the enzyme
E. A. Aragão, L. Chioato, T. L. Ferreira, A. I. de Medeiros, A. Secatto, L. H. Faccioli, R. J. Ward
3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population
R. Marrakchi, K. Bougatef, A. Moussa, S. Ouerhani, H. Khodjet-el-Khil, Y. Messai, O. Mestiri, T. Najar, A. Benammar-Elgaaeid
Enhancement of activated β1-integrin expression by prostaglandin E2 via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease
M. Kajimoto, T. Ichiyama, Y. Ueno, M. Shiraishi, M. Hasegawa, S. Furukawa